Nutriband Inc. (NTRB)
NASDAQ: NTRB · Real-Time Price · USD
6.21
-0.09 (-1.43%)
Nov 2, 2026, 1:55 PM EST - Market open
Nutriband Employees
Nutriband had 13 employees as of January 31, 2022. The number of employees increased by 8 or 160.00% compared to the previous year. That makes Nutriband the 39,638th largest employer in the world and 5,858th in the United States.
Employees
13
Change (1Y)
8
Growth (1Y)
160.00%
Revenue / Employee
$124,437
Profits / Employee
-$535,611
Market Cap
75.49M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jan 31, 2022 | 13 | 8 | 160.00% | 13 | 0 |
| Jan 31, 2021 | 5 | 2 | 66.67% | 3 | 2 |
| Jan 31, 2020 | 3 | -4 | -57.14% | 3 | 0 |
| Jan 31, 2019 | 7 | -3 | -30.00% | 3 | 4 |
| Jan 31, 2018 | 10 | 8 | 400.00% | 10 | 0 |
| Jan 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jan 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Acrivon Therapeutics | 76 |
| Rani Therapeutics Holdings | 71 |
| Tenaya Therapeutics | 70 |
| Corbus Pharmaceuticals Holdings | 36 |
| Cingulate | 14 |
| Atara Biotherapeutics | 10 |
| Rallybio | 7 |
NTRB News
- 20 days ago - Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274 - GlobeNewsWire
- 25 days ago - Nutriband files non-provisional utility Aversa patent application with USPTO - TheFly
- 25 days ago - Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology - GlobeNewsWire
- 4 weeks ago - Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders - GlobeNewsWire
- 4 weeks ago - Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis - GlobeNewsWire
- 5 weeks ago - Nutriband appoints O’Neill to Advisory Board - TheFly
- 5 weeks ago - Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing - GlobeNewsWire
- 7 weeks ago - Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit - GlobeNewsWire